• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 15, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Novel techniques for mining patented gene therapies offer promising treatment options

Bioengineer by Bioengineer
February 7, 2020
in Chemistry
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Marxa Figueiredo/Purdue University


WEST LAFAYETTE, Ind. – The global gene therapy market is expected to reach $13 billion by 2024 as new treatment options target cancers and other diseases.

Now, a team of scientists from Purdue University and other research institutions around the world have come together to better understand the growing number of worldwide patented innovations available for gene therapy treatment. They specifically focus on nonviral methods, which use synthetic or natural compounds or physical forces to deliver materials generally less toxic than their viral counterparts into the therapy treatments.

“The possibility of using nonviral vectors for gene therapy represents one of the most interesting and intriguing fields of gene therapy research,” said Marxa Figueiredo, an associate professor of basic medical sciences in Purdue’s College of Veterinary Medicine, who helped lead the research team and works with the Purdue Research Foundation Office of Technology Commercialization to patent her technologies related to health. “This is an innovative method for identifying the technological routes used by universities and companies across the world and uncovering emerging trends for different gene therapy sectors.”

The scientists used big data, patent and clinical data mining to identify technological trends for the gene therapy field. The team’s work is presented in the Feb. 7 edition of Nature Biotechnology. They envision that their analysis will help guide future developments for gene therapy.

This work brought together investigators from across the globe in a joint effort to use new databases and methods to better understand the trends of the gene therapy field in respect to nonviral vectors. Dimas Covas, coordinator of the Center for Cell-based Therapy, affiliated with the University of São Paulo in Brazil, lent his extensive experience in cell therapy. Aglaia Athanassiadou, Virginia Picanço-Castro and Figueiredo contributed their extensive experience on nonviral vectors for gene therapy. Cristiano Pereira and Geciane Porto brought their expertise in economics and business administration to the analyses. Each contribution was fundamental to achieving a new way to identify technological trends in this field.

“This work brought together investigators from very diverse disciplines to create a different perspective of the gene therapy field,” Figueiredo said. “Our groups continue to work individually or in collaboration to generate and patent new vectors to help fill the needs of this re-emerging field of nonviral gene therapy.”

###

For more information on licensing and other opportunities with the Purdue Office of Technology Commercialization, contact Joseph Kasper of OTC at jrkasper@prf.org.

About Purdue Research Foundation Office of Technology Commercialization

The Purdue Research Foundation Office of Technology Commercialization operates one of the most comprehensive technology transfer programs among leading research universities in the U.S. Services provided by this office support the economic development initiatives of Purdue University and benefit the university’s academic activities through commercializing, licensing and protecting Purdue intellectual property. The office recently moved into the Convergence Center for Innovation and Collaboration in Discovery Park District, located on the west side of the Purdue campus. The office is managed by the Purdue Research Foundation, which received the 2019 Innovation and Economic Prosperity Universities Award for Place from the Association of Public and Land-grant Universities. The Purdue Research Foundation is a private, nonprofit foundation created to advance the mission of Purdue University. Visit the Office of Technology Commercialization for more information.

Writer: Chris Adam, 765-588-3341, cladam@prf.org

Source: Marxa Figueiredo, mlfiguei@purdue.edu

Media Contact
Chris Adam
cladam@prf.org

Original Source

https://www.purdue.edu/newsroom/releases/2020/Q1/novel-techniques-for-mining-patented-gene-therapies-offer-promising-treatment-options-for-cancers,-other-diseases.html

Related Journal Article

http://dx.doi.org/10.1038/s41587-019-0402-x

Tags: BiologyBiotechnologycancerChemistry/Physics/Materials SciencesGene TherapyGenesGeneticsMedicine/HealthTechnology TransferTechnology/Engineering/Computer Science
Share13Tweet8Share2ShareShareShare2

Related Posts

Automated Synthesis Route Produces High Molar Activity Carbon-11 Phosgene from Carbon Dioxide

Automated Synthesis Route Produces High Molar Activity Carbon-11 Phosgene from Carbon Dioxide

November 15, 2026
Luffa Fiber Catalyst and Seed Oil Yield Renewable Industrial Epoxide

Luffa Fiber Catalyst and Seed Oil Yield Renewable Industrial Epoxide

November 14, 2026

Water Layer Ordering Alters Copper Catalyst Energy Barriers in Carbon Dioxide Reduction

November 14, 2026

Computational Modeling Identifies Quinolinol Analogues Outperforming Tamoxifen Against Breast Cancer Target

November 14, 2026
Please login to join discussion

POPULAR NEWS

  • Adaptive Kriging Framework Reduces Structural Reliability Evaluations by Twenty-Five Percent

    Adaptive Kriging Framework Reduces Structural Reliability Evaluations by Twenty-Five Percent

    29 shares
    Share 12 Tweet 7
  • Super-Resolution MRI Enhances Preoperative Prediction of Cervical Cancer Vascular Invasion

    29 shares
    Share 12 Tweet 7
  • Participatory Poster Design Translates Youth Flood Experiences into Local Disaster Risk Communication

    29 shares
    Share 12 Tweet 7
  • Standardized Frequency Filter Optimization Reduces Motion Sickness in Autonomous Vehicle Simulations

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Betel leaf quantum dots enable rapid fingerprint detection

New Computational Methods Narrow Price Bounds While Preserving Maximum Business Revenues

Automated Synthesis Route Produces High Molar Activity Carbon-11 Phosgene from Carbon Dioxide

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.